1 / 12

MIM’s Growing Business Segments

MIM’s Growing Business Segments. 2003 Results. $589 million Revenues $9 million Net Profit $0.41 EPS. Segment Revenue. 1Q 2004 vs. 2003. PBM/Mail. Specialty. 2004. 2003. Segment Contribution to Profitability. 1Q 2004 vs. 2003. PBM/Mail. Specialty. 2004. 2003. MIM PBM Services.

nishi
Download Presentation

MIM’s Growing Business Segments

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MIM’s Growing Business Segments

  2. 2003 Results • $589 million Revenues • $9 million Net Profit • $0.41 EPS

  3. Segment Revenue 1Q 2004 vs. 2003 PBM/Mail Specialty 2004 2003

  4. Segment Contribution to Profitability 1Q 2004 vs. 2003 PBM/Mail Specialty 2004 2003

  5. MIM PBM Services • 200 payor clients • Approximately 7 million lives under management • Processed or delivered 12 million prescriptions

  6. MIM BioScrip Competitive Value • Payor-centric model • Over 350 payor contracts with access to over 20 million lives • Clinical approach combined with education • Center of excellence in specific disease state management • Superior Reporting Capabilities

  7. MIM BioScrip Competitive Value (Continued) • National and local presence • Regional physician sales force targeting specialists • Specialized mixing & fulfillment facilities • Dominant player in NY metropolitan area • Recently completed specialty acquisition

  8. Disease States Driving Growth Crohn’s Disease Gaucher’s Disease Growth Hormone Deficiency HIV/AIDS Hemophilia Hepatitis C Immune Deficiency Infertility MS Oncology Psoriasis Renal Care Organ Transplant Rheumatoid Arthritis • Provide all drugs across all therapeutic categories

  9. Revenue Mix Among Disease States

  10. MIM BioScrip PhilosophyPersonalized medicine Payor-centric approachLocal relationships

More Related